46 related articles for article (PubMed ID: 12972451)
1. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora.
Seppälä H; Haanperä M; Al-Juhaish M; Järvinen H; Jalava J; Huovinen P
J Antimicrob Chemother; 2003 Oct; 52(4):636-44. PubMed ID: 12972451
[TBL] [Abstract][Full Text] [Related]
2. Genetic characterization of optochin-susceptible viridans group streptococci.
Martín-Galiano AJ; Balsalobre L; Fenoll A; de la Campa AG
Antimicrob Agents Chemother; 2003 Oct; 47(10):3187-94. PubMed ID: 14506029
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of viridans streptococci to leaf extracts of Mangifera Indica.
Jose S; Beegum GR
Indian J Microbiol; 2007 Jun; 47(2):160-3. PubMed ID: 23100659
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic resistance, bacterial transmission and improved prediction of bacterial infection in patients with antibody deficiency.
Rofael S; Leboreiro Babe C; Davrandi M; Kondratiuk AL; Cleaver L; Ahmed N; Atkinson C; McHugh T; Lowe DM
JAC Antimicrob Resist; 2023 Dec; 5(6):dlad135. PubMed ID: 38098890
[TBL] [Abstract][Full Text] [Related]
5. Editorial Commentary: Impact of Fluoroquinolone Prophylaxis on Viridans Group Streptococci Bloodstream Infections in Immunocompromised Children.
Acker KP
J Pediatric Infect Dis Soc; 2023 Jul; 12(7):392-393. PubMed ID: 37490395
[No Abstract] [Full Text] [Related]
6. Correction to: Emerging Resistance Trends in Viridans Group Streptococci Bloodstream Infections Among Immunocompromised Children Receiving Levofloxacin Prophylaxis.
J Pediatric Infect Dis Soc; 2023 Oct; 12(10):557. PubMed ID: 37721551
[No Abstract] [Full Text] [Related]
7. Microbiological Epidemiology of Invasive Infections Due to Non-Beta-Hemolytic Streptococci, France, 2021.
Plainvert C; Matuschek E; Dmytruk N; Gaillard M; Frigo A; Ballaa Y; Biesaga E; Kahlmeter G; Poyart C; Tazi A
Microbiol Spectr; 2023 Jun; 11(3):e0016023. PubMed ID: 37199642
[TBL] [Abstract][Full Text] [Related]
8. An Overview of Macrolide Resistance in Streptococci: Prevalence, Mobile Elements and Dynamics.
Berbel D; González-Díaz A; López de Egea G; Càmara J; Ardanuy C
Microorganisms; 2022 Nov; 10(12):. PubMed ID: 36557569
[TBL] [Abstract][Full Text] [Related]
9. Pyruvate secretion by oral streptococci modulates hydrogen peroxide dependent antagonism.
Redanz S; Treerat P; Mu R; Redanz U; Zou Z; Koley D; Merritt J; Kreth J
ISME J; 2020 May; 14(5):1074-1088. PubMed ID: 31988475
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs).
Yim J; Smith JR; Singh NB; Rice S; Stamper K; Garcia de la Maria C; Bayer AS; Mishra NN; Miró JM; Tran TT; Arias CA; Sullam P; Rybak MJ
J Antimicrob Chemother; 2017 Aug; 72(8):2290-2296. PubMed ID: 28475731
[TBL] [Abstract][Full Text] [Related]
11. Macrolide Resistance in
Schroeder MR; Stephens DS
Front Cell Infect Microbiol; 2016; 6():98. PubMed ID: 27709102
[No Abstract] [Full Text] [Related]
12. Characterization of high-level daptomycin resistance in Viridans group Streptococci developed upon in vitro exposure to daptomycin.
Akins RL; Katz BD; Monahan C; Alexander D
Antimicrob Agents Chemother; 2015 Apr; 59(4):2102-12. PubMed ID: 25624330
[TBL] [Abstract][Full Text] [Related]
13. Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin.
García-de-la-Mària C; Pericas JM; Del Río A; Castañeda X; Vila-Farrés X; Armero Y; Espinal PA; Cervera C; Soy D; Falces C; Ninot S; Almela M; Mestres CA; Gatell JM; Vila J; Moreno A; Marco F; Miró JM;
Antimicrob Agents Chemother; 2013 May; 57(5):2319-25. PubMed ID: 23478959
[TBL] [Abstract][Full Text] [Related]
14. Identification of a pheA gene associated with Streptococcus mitis by using suppression subtractive hybridization.
Park HK; Dang HT; Myung SC; Kim W
Appl Environ Microbiol; 2012 Apr; 78(8):3004-9. PubMed ID: 22307284
[TBL] [Abstract][Full Text] [Related]
15. Influence of azithromycin and clarithromycin on macrolide susceptibility of viridans streptococci from the oral cavity of healthy volunteers.
Eisenblätter M; Klaus C; Pletz MW; Orawa H; Hahn H; Wagner J; Lode H
Eur J Clin Microbiol Infect Dis; 2008 Nov; 27(11):1087-92. PubMed ID: 18512087
[TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology of macrolide and tetracycline resistances in commensal Gemella sp. isolates.
Zolezzi PC; Cepero PG; Ruiz J; Laplana LM; Calvo CR; Gómez-Lus R
Antimicrob Agents Chemother; 2007 Apr; 51(4):1487-90. PubMed ID: 17283201
[TBL] [Abstract][Full Text] [Related]
17. Identification of alpha-hemolytic streptococci by pyrosequencing the 16S rRNA gene and by use of VITEK 2.
Haanperä M; Jalava J; Huovinen P; Meurman O; Rantakokko-Jalava K
J Clin Microbiol; 2007 Mar; 45(3):762-70. PubMed ID: 17215341
[TBL] [Abstract][Full Text] [Related]
18. Erythromycin resistance and genetic elements carrying macrolide efflux genes in Streptococcus agalactiae.
Marimón JM; Valiente A; Ercibengoa M; García-Arenzana JM; Pérez-Trallero E
Antimicrob Agents Chemother; 2005 Dec; 49(12):5069-74. PubMed ID: 16304174
[TBL] [Abstract][Full Text] [Related]
19. Molecular detection of the macrolide efflux gene: to discriminate or not to discriminate between mef(A) and mef(E).
Klaassen CH; Mouton JW
Antimicrob Agents Chemother; 2005 Apr; 49(4):1271-8. PubMed ID: 15793097
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
